Advanced search
Publication Cover
Current Medical Research and Opinion Volume 25, 2009 - Issue 6
Submit an article Journal homepage
809
Views
23
CrossRef citations to date
0
Altmetric
Review

New directions in the treatment of systemic lupus erythematosus

Kenneth Kalunian UCSD School of Medicine, La Jolla, CA, USACorrespondence[email protected]
&
T. Merrill Joan Oklahoma Medical Research Foundation, Oklahoma City, OK, USA
Pages 1501-1514 | Accepted 27 Mar 2009, Published online: 11 May 2009

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Cindy Garris, Priti Jhingran, Damon Bass, Nicole M. Engel-Nitz, Aylin Riedel & Greg Dennis. (2013) Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan. Journal of Medical Economics 16:5, pages 667-677.
Read now
S Pettersson, M Lövgren, LE Eriksson, C Moberg, E Svenungsson, I Gunnarsson & E Welin Henriksson. (2012) An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life. Scandinavian Journal of Rheumatology 41:5, pages 383-390.
Read now

Articles from other publishers (21)

Edward R Hammond, Barnabas Desta, Aimee M Near, Xia Wang & Miao Jiang. (2021) Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004–2015. Lupus Science & Medicine 8:1, pages e000504.
Crossref
Miao Jiang, Aimee M Near, Barnabas Desta, Xia Wang & Edward R Hammond. (2021) Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004–2015. Lupus Science & Medicine 8:1, pages e000503.
Crossref
Cora W Hannon, Collette McCourt, Hermenio C Lima, Suephy Chen & Cathy Bennett. (2021) Interventions for cutaneous disease in systemic lupus erythematosus. Cochrane Database of Systematic Reviews 2021:3.
Crossref
Andrés A. Herrada, Noelia Escobedo, Mirentxu Iruretagoyena, Rodrigo A. Valenzuela, Paula I. Burgos, Loreto Cuitino & Carolina Llanos. (2019) Innate Immune Cells' Contribution to Systemic Lupus Erythematosus. Frontiers in Immunology 10.
Crossref
S Kabadi, J Yeaw, A K Bacani, E Tafesse, K Bos, S Karkare, M DeKoven & E R Vina. (2018) Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus. Lupus 27:11, pages 1799-1809.
Crossref
X Ng, S dosReis, R Beardsley, L Magder, C D Mullins & M Petri. (2017) Understanding systemic lupus erythematosus patients' desired outcomes and their perceptions of the risks and benefits of using corticosteroids. Lupus 27:3, pages 475-483.
Crossref
T Kent, A Davidson, D Newman, G Buck & D D’Cruz. (2017) Burden of illness in systemic lupus erythematosus: results from a UK patient and carer online survey. Lupus 26:10, pages 1095-1100.
Crossref
David A. Hart. (2016) Sex-specific effects of LiCl treatment on preservation of renal function and extended life-span in murine models of SLE: perspective on insights into the potential basis for survivorship in NZB/W female mice. Biology of Sex Differences 7:1.
Crossref
Davood Rostamzadeh, Seyed Rasol Razavi, Shadi Esmaeili, Sanam Dolati, Majid Ahmahi, Sanam Sadreddini, Farhad Jadidi-Niaragh & Mehdi Yousefi. (2016) Application of nanoparticle technology in the treatment of Systemic lupus erythematous. Biomedicine & Pharmacotherapy 83, pages 1154-1163.
Crossref
Li-qiang Wei, Yong-gang Liang, Yong Zhao, Hui-tao Liang, Dong-chun Qin & Ming-cong She. (2016) Efficacy and Safety of Belimumab Plus Standard Therapy in Patients With Systemic Lupus Erythematosus: A Meta-analysis. Clinical Therapeutics 38:5, pages 1134-1140.
Crossref
Olga Ruiz-Andres, Beatriz Suarez-Alvarez, Cristina Sánchez-Ramos, Maria Monsalve, Maria D. Sanchez-Niño, Marta Ruiz-Ortega, Jesús Egido, Alberto Ortiz & Ana B. Sanz. (2016) The inflammatory cytokine TWEAK decreases PGC-1α expression and mitochondrial function in acute kidney injury. Kidney International 89:2, pages 399-410.
Crossref
M Petri, B Bechtel, G Dennis, M Shah, T McLaughlin, H Kan & C Molta. (2014) Burden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel. Lupus 23:10, pages 1006-1013.
Crossref
Maryam Al Hussaini, Emad I. Hammouda & Ahmed E. Hammouda. (2014) Optimizing pharmacotherapy of systemic lupus erythematosus: the pharmacist role. International Journal of Clinical Pharmacy 36:4, pages 684-692.
Crossref
Wen Xiong & Robert G. Lahita. (2013) Pragmatic approaches to therapy for systemic lupus erythematosus. Nature Reviews Rheumatology 10:2, pages 97-107.
Crossref
Manan Shah, Sham Chaudhari, Trent P. McLaughlin, Hong J. Kan, Benno Bechtel, Gregory J. Dennis & Charles T. Molta. (2013) Cumulative Burden of Oral Corticosteroid Adverse Effects and the Economic Implications of Corticosteroid Use in Patients With Systemic Lupus Erythematosus. Clinical Therapeutics 35:4, pages 486-497.
Crossref
Michelle Petri, Daniel J. Wallace, Alberto Spindler, Vishala Chindalore, Kenneth Kalunian, Eduardo Mysler, C. Michael Neuwelt, Gabriel Robbie, Wendy I. White, Brandon W. Higgs, Yihong Yao, Liangwei Wang, Dominique Ethgen & Warren Greth. (2013) Sifalimumab, a Human Anti–Interferon‐α Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose‐Escalation Study. Arthritis & Rheumatism 65:4, pages 1011-1021.
Crossref
Samuel L. Gurevitz, Jennifer A. Snyder, Eric K. Wessel, Julianne Frey & Bridget A. Williamson. (2013) Systemic Lupus Erythematosus: A Review of the Disease and Treatment Options. The Consultant Pharmacist 28:2, pages 110-121.
Crossref
A. Oglesby, A. J. Shaul, T. Pokora, C. Paramore, L. Cragin, G. Dennis, S. Narayanan & A. Weinstein. (2013) Adverse Event Burden, Resource Use, and Costs Associated with Immunosuppressant Medications for the Treatment of Systemic Lupus Erythematosus: A Systematic Literature Review. International Journal of Rheumatology 2013, pages 1-9.
Crossref
Katherine A. Slawsky, Ancilla W. Fernandes, Lauren Fusfeld, Susan Manzi & Thomas F. Goss. (2011) A structured literature review of the direct costs of adult systemic lupus erythematosus in the US. Arthritis Care & Research 63:9, pages 1224-1232.
Crossref
Sandra V Navarra, Renato M Guzmán, Alberto E Gallacher, Stephen Hall, Roger A Levy, Renato E Jimenez, Edmund K-M Li, Mathew Thomas, Ho-Youn Kim, Manuel G León, Coman Tanasescu, Eugeny Nasonov, Joung-Liang Lan, Lilia Pineda, Z John Zhong, William Freimuth & Michelle A Petri. (2011) Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. The Lancet 377:9767, pages 721-731.
Crossref
Nadia Mama-Larbi, Kalthoum Tlili-Graiess, Anis Askri, Ahmed Laatar, Amira Manamani, Leith Zakraoui & Lotfi Hendaoui. 2012. Systemic Vasculitis. Systemic Vasculitis 315 326 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.